Abraxane Injection, Powder, Lyophilized, For Suspension
Product Images NDC 68817-134

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Abraxane (NDC 68817-134). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Abraxis Bioscience, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Slowly Inject The 20 mL Of 0.9% Sodium Chloride Injection, Usp, Over A Minimum Of 1 Minute, Using The Sterile Syringe To Direct The Solution Flow Onto The Inside Wall Of The Vial. (Abraxane 01)

An instructional illustration showing a vial being held upside down with a syringe inserted into the rubber stopper, demonstrating the technique for drawing a solution from an injection vial.*

FDA Label Image

Structural Formula For Paclitaxel (Abraxane 02)

Chemical structure of paclitaxel shown as a detailed molecular diagram with labeled atoms and bonds, depicting its complex multi-ring structure with various functional groups.*

FDA Label Image

Figure 1: Kaplan-meier Curve Of Overall Survival (intent-to-treat Population) (Abraxane 03)

This is a survival curve chart depicting the proportion of survival over time in months for patients treated with ABRAXANE plus Gemcitabine versus Gemcitabine alone. The solid line represents ABRAXANE plus Gemcitabine, and the dotted line represents Gemcitabine. The chart includes patient numbers at risk for each treatment group across time intervals.*

FDA Label Image

Principal Display Panel (100 mg Vial)

ABRAXANE 100 mg per vial for Injectable Suspension label for paclitaxel protein-bound particles (albumin-bound). The label specifies it is a single-use vial for intravenous use only and emphasizes not to substitute different paclitaxel products. It includes product handling instructions, manufacturer information (Abraxis BioScience, LLC), and a barcode for the NDC 68817-134-50.*

FDA Label Image

Principal Display Panel (100 mg Vial)

ABRAXANE 100 mg per vial injectable suspension (paclitaxel protein-bound particles for injectable suspension) label shows it is a single-use vial for intravenous use only, not to be substituted with other paclitaxel products. The label includes dosage strength, route, manufacturer Abraxis BioScience, LLC, and a barcode with NDC 68817-134-50.*

FDA Label Image

Principal Display Panel (100 mg Vial Carton)

ABRAXANE 100 mg per vial injection, lyophilized powder for suspension, intravenous use only, by Abraxis BioScience, LLC. The carton includes dosage form details, storage instructions to keep refrigerated at 20°C to 25°C, and warnings to verify dosage and infusion rate. The label states the product is albumin-bound paclitaxel with single-use vial instructions and a barcode is visible on the package.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.